Clinical Autonomic Research

, Volume 22, Issue 6, pp 303–306

Temporary elimination of orthostatic hypotension by norepinephrine infusion

  • David S. Goldstein
  • LaToya Sewell
  • Courtney Holmes
  • Sandra Pechnik
  • André Diedrich
  • David Robertson
Short Communication

Abstract

A cardinal manifestation of chronic autonomic failure is neurogenic orthostatic hypotension (OH), which often is associated with supine hypertension, posing a therapeutic dilemma. We report here success in a first step toward development of a “prosthetic baroreceptor system” to maintain blood pressure during orthostasis without worsening supine hypertension. In all of four patients with neurogenic OH, titrated i.v. NE infusion kept directly recorded intra-arterial pressure at or above baseline during progressive head-up tilt. We conclude that titrated i.v. NE infusion temporarily eliminates OH.

Keywords

Norepinephrine Orthostatic hypotension Sympathetic nervous system Baroreflex 

Abbreviations

NE

Norepinephrine

OH

Orthostatic hypotension

References

  1. 1.
    Goldstein DS, Zimlichman R, Stull R, Keiser HR, Kopin IJ (1986) Estimation of intrasynaptic norepinephrine concentrations in humans. Hypertension 8:471–475PubMedCrossRefGoogle Scholar
  2. 2.
    Holmes C, Eisenhofer G, Goldstein DS (1994) Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653:131–138PubMedCrossRefGoogle Scholar
  3. 3.
    Kaufmann H, Biaggioni I (2003) Autonomic failure in neurodegenerative disorders. Semin Neurol 23:351–363PubMedCrossRefGoogle Scholar
  4. 4.
    Kribben A, Bremer C, Fritschka E, Koeppen S, Ahrens O, Philipp T (1998) Ambulatory infusion of noradrenaline for long-term treatment of Shy-Drager syndrome. Kidney Blood Press Res 21:70–73PubMedCrossRefGoogle Scholar
  5. 5.
    Lehmann M, Petersen KG, Khalaf AN (1991) Sympathetic autonomic dysfunction. Programmed subcutaneous noradrenaline administration via microdosing pump. Klin Wochenschr 69:872–879PubMedCrossRefGoogle Scholar
  6. 6.
    Lehmann M, Petersen KG, Khalaf AN, Haussinger D, Buchner C, Sellinger M, Peter K (1990) Improvement of the exercise capacity of a patient with primary orthostatic hypotension (primary sympathetic insufficiency) by programmed subcutaneous noradrenaline administration via microdosing pump. Klin Wochenschr 68:873PubMedCrossRefGoogle Scholar
  7. 7.
    Oldenburg O, Erbel R, Fritschka E, Philipp T, Kribben A (1999) Ambulatory norepinephrine infusion in severe idiopathic orthostatic hypotension (Bradbury Eggleston syndrome). Cardiovasc Drugs Ther 13:355–356PubMedCrossRefGoogle Scholar
  8. 8.
    Oldenburg O, Mitchell A, Nurnberger J, Koeppen S, Erbel R, Philipp T, Kribben A (2001) Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension. J Am Coll Cardiol 37:219–223PubMedCrossRefGoogle Scholar
  9. 9.
    Polinsky RJ, Samaras GM, Kopin IJ (1983) Sympathetic neural prosthesis for managing orthostatic hypotension. Lancet 1:901–904PubMedCrossRefGoogle Scholar
  10. 10.
    Senard JM, Valet P, Durrieu G, Berlan M, Tran MA, Montastruc JL, Rascol A, Montastruc P (1990) Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest 20:613–619PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag (outside the USA)  2012

Authors and Affiliations

  • David S. Goldstein
    • 1
  • LaToya Sewell
    • 1
  • Courtney Holmes
    • 1
  • Sandra Pechnik
    • 1
  • André Diedrich
    • 2
  • David Robertson
    • 3
  1. 1.Clinical Neurocardiology SectionNational Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesdaUSA
  2. 2.Department of Biomedical EngineeringVanderbilt UniversityNashvilleUSA
  3. 3.Autonomic Dysfunction CenterVanderbilt University School of MedicineNashvilleUSA

Personalised recommendations